Oxford BioMedica (UK) Ltd
Silver
Information
Oxford Biomedica is a quality and innovation-led CDMO with over 25 years of experience, committed to helping our clients deliver cell and gene therapies that transform patients’ lives. We offer end-to-end capabilities, from plasmid design and optimization, to clinical and commercial CGMP manufacturing, accompanied by robust control systems, analytical methods, and deep regulatory knowledge. Our expertise across lentivirus, AAV, and adenoviral vectors is relied upon by some of the world’s most successful biotechnology and pharmaceutical companies.
